Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT07604558
PHASE1

A Study to Assess the Adverse Events and How Bretisilocin Intramuscular Injection Moves Through the Body of Healthy Adult Participants

Sponsor: AbbVie

View on ClinicalTrials.gov

Summary

This study will assess the adverse events, tolerability, and how bretisilocin intramuscular (IM) Injection moves through the body of healthy adult Japanese, Han Chinese, and Non-Asian volunteers participants.

Official title: An Open-Label Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of a Single Dose of Bretisilocin in Healthy Adult Japanese, Han Chinese, and Non-Asian Volunteers

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

26

Start Date

2026-05-26

Completion Date

2026-09-03

Last Updated

2026-09-30

Healthy Volunteers

Yes

Interventions

DRUG

Bretisilocin

Intramuscular Injection

Locations (1)

CenExel Collaborative Neuroscience Research /ID# 281612

Los Alamitos, California, United States